Globe Life (NYSE:GL) Upgraded at Texas Capital

Texas Capital upgraded shares of Globe Life (NYSE:GL) to a strong-buy rating in a research note published on Wednesday,Zacks.com reports.

Several other equities analysts have also issued reports on the stock. JPMorgan Chase & Co. boosted their target price on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Evercore set a $157.00 price target on Globe Life in a report on Wednesday, February 18th. Piper Sandler reissued an “overweight” rating and issued a $167.00 price objective on shares of Globe Life in a research report on Friday, November 21st. Truist Financial boosted their price objective on Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research note on Friday, February 6th. Finally, Wells Fargo & Company upped their target price on Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a research report on Wednesday, February 25th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $171.33.

Globe Life Stock Down 0.6%

Shares of GL opened at $136.85 on Wednesday. The stock’s 50-day moving average price is $141.82 and its two-hundred day moving average price is $138.95. Globe Life has a 12 month low of $109.38 and a 12 month high of $152.71. The company has a market capitalization of $10.76 billion, a PE ratio of 9.72 and a beta of 0.46. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.30%. The company had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the company posted $3.14 EPS. The company’s quarterly revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, analysts anticipate that Globe Life will post 13.87 EPS for the current year.

Globe Life Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. This represents a $1.32 annualized dividend and a dividend yield of 1.0%. Globe Life’s payout ratio is presently 9.38%.

Insider Buying and Selling at Globe Life

In related news, CEO Frank M. Svoboda sold 12,500 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total value of $1,809,750.00. Following the completion of the sale, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at approximately $5,192,969.04. This represents a 25.84% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO James Matthew Darden sold 18,318 shares of the firm’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $145.10, for a total value of $2,657,941.80. Following the transaction, the chief executive officer owned 51,093 shares in the company, valued at approximately $7,413,594.30. This trade represents a 26.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 82,807 shares of company stock valued at $12,041,286 in the last three months. Insiders own 1.51% of the company’s stock.

Institutional Trading of Globe Life

Several hedge funds have recently made changes to their positions in GL. Mather Group LLC. bought a new position in shares of Globe Life during the 3rd quarter worth $28,000. Hilton Head Capital Partners LLC purchased a new stake in Globe Life in the 4th quarter worth about $30,000. CYBER HORNET ETFs LLC purchased a new stake in Globe Life in the 2nd quarter worth about $28,000. MUFG Securities EMEA plc bought a new stake in Globe Life in the 2nd quarter valued at about $31,000. Finally, Quent Capital LLC bought a new stake in Globe Life in the 3rd quarter valued at about $36,000. 81.61% of the stock is currently owned by institutional investors.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.